In Vitro Effects of Selenium on Human Glioblastoma Multiforme Cell Lines: A Preliminary Study
- PMID: 29120131
- DOI: 10.20471/acc.2017.56.01.08
In Vitro Effects of Selenium on Human Glioblastoma Multiforme Cell Lines: A Preliminary Study
Abstract
Glioblastoma multiforme (GBM) is caused by the central nervous system-derived glial cells, and represents the most common (50%-60%) form of primary brain tumors. The aim of this study was to investigate the in vitro effects of selenium on human GBM cells. In the present study, GMS-10 and DBTRG-05MG human GBM cell lines were used as a model to examine selenium entering the cell, cell proliferation, cytotoxicity, DNA fragmentation and Ki-67 protein expression in selenomethionine treated and non-treated groups. Seleno-L-methionine (SeMet) as the organic source of selenium exerted effects on cell proliferation and cytotoxicity, as assessed with WST-1 and lactate dehydrogenase (LDH) tests, respectively. Apoptosis was assessed by DNA fragmentation with an enzyme-linked immunosorbent assay. Ki-67 protein expression was determined by Western blotting, while selenium measurements were performed in the supernatants and lysates by using Graphite Furnace Atomic Absorption Spectrometry. This is the first study to examine the effects of SeMet on cell proliferation and death in GMS-10 and DBTRG-05MG cells. Both GBM cell lines responded to SeMet in a dose- and time-dependent manner. WST-1 test showed that low-dose SeMet treatment (50 and 100 μM) increased cell proliferation. Analysis of intracellular SeMet levels by using AAS showed results consistent with viability and cytotoxicity tests. SeMet treatment for 72h caused increased DNA fragmentation in both cell lines. In conclusion, our results suggest that SeMet induces cell death at high doses, while increasing cell proliferation at low doses. In the view of the data obtained in this investigation, further studies focusing on the possibility of using SeMet against different types of GBM and in combination with prospect synergic compounds are considered to be worthwhile.
Keywords: Glioblastoma – therapy; Anticarcinogenic agents; Humans; Selenium; Selenomethionine; Cell proliferation – drug effects; Cell death – drug effects; Cytotoxicity; Ki-67 antigen.
Similar articles
-
Therapeutic Potential of Selenium in Glioblastoma.Front Neurosci. 2021 May 28;15:666679. doi: 10.3389/fnins.2021.666679. eCollection 2021. Front Neurosci. 2021. PMID: 34121995 Free PMC article. Review.
-
Responses of an American eel brain endothelial-like cell line to selenium deprivation and to selenite, selenate, and selenomethionine additions in different exposure media.In Vitro Cell Dev Biol Anim. 2017 Dec;53(10):940-953. doi: 10.1007/s11626-017-0196-4. Epub 2017 Sep 22. In Vitro Cell Dev Biol Anim. 2017. PMID: 28940125
-
Long-term selenium supplementation in HaCaT cells: importance of chemical form for antagonist (protective versus toxic) activities.Biol Trace Elem Res. 2013 Aug;154(2):288-98. doi: 10.1007/s12011-013-9709-5. Epub 2013 Jun 16. Biol Trace Elem Res. 2013. PMID: 23771685
-
Six-day selenium supplementation led to either UVA-photoprotection or toxic effects in human fibroblasts depending on the chemical form and dose of Se.Metallomics. 2014 Sep;6(9):1683-92. doi: 10.1039/c4mt00040d. Metallomics. 2014. PMID: 24994457
-
Selenomethionine: A Pink Trojan Redox Horse with Implications in Aging and Various Age-Related Diseases.Antioxidants (Basel). 2021 May 31;10(6):882. doi: 10.3390/antiox10060882. Antioxidants (Basel). 2021. PMID: 34072794 Free PMC article. Review.
Cited by
-
Preparative Biocatalytic Synthesis of α-Ketomethylselenobutyrate-A Putative Agent for Cancer Therapy.Molecules. 2023 Aug 22;28(17):6178. doi: 10.3390/molecules28176178. Molecules. 2023. PMID: 37687007 Free PMC article.
-
Altered Elemental Distribution in Male Rat Brain Tissue as a Predictor of Glioblastoma Multiforme Growth-Studies Using SR-XRF Microscopy.Int J Mol Sci. 2022 Jan 9;23(2):703. doi: 10.3390/ijms23020703. Int J Mol Sci. 2022. PMID: 35054889 Free PMC article.
-
PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS.Acta Clin Croat. 2019 Sep;58(3):455-462. doi: 10.20471/acc.2019.58.03.08. Acta Clin Croat. 2019. PMID: 31969757 Free PMC article.
-
Selenium Compounds as Novel Potential Anticancer Agents.Int J Mol Sci. 2021 Jan 20;22(3):1009. doi: 10.3390/ijms22031009. Int J Mol Sci. 2021. PMID: 33498364 Free PMC article. Review.
-
Therapeutic Potential of Selenium in Glioblastoma.Front Neurosci. 2021 May 28;15:666679. doi: 10.3389/fnins.2021.666679. eCollection 2021. Front Neurosci. 2021. PMID: 34121995 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical